A Potential Role for Avocado- and Soybean-Based Nutritional Supplements in the Management of Osteoarthritis: A Review

References

• . Ameye LG, Chee WS. Osteoarthritis and nutrition. From nutraceuticals to functional foods: a systematic review of the scientific evidence. Arthritis Res Ther. 2006;8(4):R127
   PubMed Web of Science ®Google Scholar
• . Helmick CG, Felson DT, Lawrence RC, ; National Arthritis Data Workgroup. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States Part I. Arthritis Rheum. 2008;58(1):15–25
   PubMed Web of Science ®Google Scholar
• . Lawrence RC, Felson DT, Helmick CG, ; National Arthritis Data Workgroup. Estimates of the prevalence of arthritis and other rheumatic condition in the United States Part II. Arthritis Rheum. 2008;58(1):26–35
   PubMed Web of Science ®Google Scholar
• . Gupta S, Hawker GA, Laporte A, Croxford R, Coyte PC. The economic burden of disabling hip and knee osteoarthritis (OA) from the perspective of individuals living with this condition. Rheumatology (Oxford). 2005;44(12):1531–1537
   PubMed Web of Science ®Google Scholar
• . Kurtz SM, Ong KL, Schmier J, Zhao K, Mowat F, Lau E. Primary and revision arthroplasty surgery caseloads in the United States from 1990 to 2004. J Arthroplasty. 2009;24(2):195–203
   PubMed Web of Science ®Google Scholar
• . Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Arthritis Rheum. 2000;43(9):1905–1915
   PubMed Web of Science ®Google Scholar
• . Deal CL, Moskowitz RW. Nutraceuticals as therapeutic agents in osteoarthritis. The role of glucosamine, chondroitin sulfate, and collagen hydrolysate. Rheum Dis Clin North Am. 1999;25(2):379–395
   PubMed Web of Science ®Google Scholar
• . Gislason GH, Rasmussen JN, Abildstrom SZ, . Increased mortality and cardiovascular morbidity associated with use of nonsteroidal anti-inflammatory drugs in chronic heart failure. Arch Intern Med. 2009;169(2):141–149
   PubMed Web of Science ®Google Scholar
• . Battistella M, Mamdami MM, Juurlink DN, . Risk of upper gastrointestinal hemorrhage in warfarin users treated with nonselective NSAIDs or COX-2 inhibitors. Arch Intern Med. 2005;165(2):189–192
   PubMedGoogle Scholar
• . Frech TM, Clegg DO. The utility of nutraceuticals in the treatment of osteoarthritis. Curr Rheumatol Rep. 2007;9(1):25–30
   PubMedGoogle Scholar
• . Ernst E. Avocado-soybean unsaponifiables (ASU) for osteoarthritis – a systematic review. Clin Rheumatol. 2003;22(4–5):285–288
   PubMed Web of Science ®Google Scholar
• . Little CV, Parsons T. Herbal therapy for treating osteoarthritis. Cochrane Database Syst Rev. 2001;(1):CD002947
   Google Scholar
• . Christensen R, Bartels EM, Astrup A, Bliddal H. Symptomatic efficacy of avocado-soybean unsaponifiables (ASU) in osteoarthritis (OA) patients: a meta-analysis of randomized controlled trials. Osteoarthritis Cartilage. 2008;16(4):399–408
   PubMed Web of Science ®Google Scholar
• . Packaged Facts. http://www.packagedfacts.com. Accessed May 30, 2010
   Google Scholar
• . Gabay O, Gosset M, Levy A, . Stress-induced signaling pathways in hyalin chondrocytes: inhibition by avocado-soybean unsaponifiables (ASU). Osteoarthritis Cartilage. 2008;16(3):373–384
   PubMed Web of Science ®Google Scholar
• . Jacques C, Gosset M, Berenbaum F, Gabay C. The role of IL-1 and IL-1Ra in joint inflammation and cartilage degradation. Vitam Horm. 2006;74:371–403
   PubMed Web of Science ®Google Scholar
• . van der Kraan PM, van den Berg WB. Anabolic and destructive mediators in osteoarthritis. Curr Opin Clin Nutr Metab Care. 2000;3(3):205–211
   PubMedGoogle Scholar
• . Goldring MB, Berenbaum F. The regulation of chondrocyte function by proinflammatory mediators: prostaglandins and nitric oxide. Clin Orthop Relat Res. 2004;( 427 suppl):S37–S46
   Google Scholar
• . Goldring MB, Birkhead JR, Suen LF, . Interleukin-1 beta-modulated gene expression in immortalized human chondrocytes. J Clin Invest. 1994;94(6):2307–2316
   PubMed Web of Science ®Google Scholar
• . Lotz M, Rosen F, McCabe G, . Interleukin 1 beta suppresses transforming growth factor-induced inorganic pyrophosphate (PPi) production and expression of the PPi-generating enzyme PC-1 in human chondrocytes. Proc Natl Acad Sci U S A. 1995;92(22):10364–10368
   PubMed Web of Science ®Google Scholar
• . Berenbaum F. Signaling transduction: target in osteoarthritis. Curr Opin Rheumatol. 2004;16(5):616–622
   PubMed Web of Science ®Google Scholar
• . Anderson JW, Nicolosi RJ, Borzelleca JF. Glucosamine effects in humans: a review of effects on glucose metabolism, side effects, safety considerations and efficacy. Food Chem Toxicol. 2005;43(2):187–201
   PubMed Web of Science ®Google Scholar
• . Barclay TS, Tsourounis C, McCart GM. Glucosamine. Ann Pharmacother. 1998;32(5):574–579
   PubMed Web of Science ®Google Scholar
• . Fenton JI, Chlebek-Brown KA, Peters TL, Caron JP, Orth MW. Glucosamine HCl reduces equine articular cartilage degradation in explant culture. Osteoarthritis Cartilage. 2000;8(4):258–265
   PubMed Web of Science ®Google Scholar
• . Chan PS, Caron JP, Orth MW. Short-term gene expression changes in cartilage explant cultures stimulated with interleukin beta plus glucosamine and chondroitin sulfate. J Rheumatol. 2006;33(7):1329–1340
   PubMed Web of Science ®Google Scholar
• . Towheed T, Maxwell L, Anastassiades TP, . Glucosamine therapy for treating osteoarthritis. Cochrane Database Syst Rev. 2005;2:CD002946
   Google Scholar
• . Volpi N, Mucci A. Characterization of a low-sulfated chondroitin sulfate from the body of Viviparus ater (mollusca gastropoda). Modification of its structure by lead pollution. Glycoconj J. 1998;15(11):1071–1078
   PubMed Web of Science ®Google Scholar
• . Au RY, Phan PV, Au RY, Griffin D, Frondoza CG. Effect of different chondroitin sulfate raw materials on pro-inflammatory gene expression in bovine chondrocytes. Presented at 34th Annual Conference Veterinary Orthopedic Society. Keystone, CO; 2006
   Google Scholar
• . Phan PV, Au RY, Grzanna M, . Pro-inflammatory gene expression is inhibited by chondroitin sulfate in chondrocytes and monocytes. Oral presentation. Transactions of the 2nd World Veterinary Orthopaedic Congress and 33rd Annual VOS Meeting. Keystone, CO: February 25-March 4, 2006:118
   Google Scholar
• . Phan PV, Au RY, Au AY, . Chemokine gene expression and production is inhibited by chondroitin sulfate in synoviocytes and dermal fibroblasts. Presented at: 34th Annual Conference Veterinary Orthopedic Society. Sun Valley, ID; May 3–10, 2007
   Google Scholar
• . Michel BA, Stucki G, Frey D, . Chondroitins 4 and 6 sulfate in osteoarthritis of the knee. Arthritis Rheum. 2005;52(3):779–786
   PubMed Web of Science ®Google Scholar
• . Kahan A, Uebelhart D, De Vathaire F, Delams PD, Reginster JY. Long-term effects of chondroitins 4 and 6 sulfate on knee osteoarthritis: the study on osteoarthritis progression prevention, a two-year, randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2009;60(2):524–533
   PubMed Web of Science ®Google Scholar
• . Johnson KA, Hulse DA, Hart RC, Kochevar D, Chu Q. Effects of an orally administered mixture of chondroitin sulfate, glucosamine hydrochloride and manganese ascorbate on synovial fluid chondroitin sulfate 3B3 and 7D4 epitope in a canine cruciate ligament transection model of osteoarthritis. Osteoarthritis Cartilage. 2001;9(1):14–21
   PubMed Web of Science ®Google Scholar
• . Lippiello L, Woodward J, Karpman R, Hammad TA. In vivo chondroprotection and metabolic synergy of glucosamine and chondroitin sulfate. Clin Orthop Relat Res. 2000;381:229–240
   PubMed Web of Science ®Google Scholar
• . Homandberg GA. Potential regulation of cartilage metabolism in osteoarthritis by fibronectin fragments. Front Biosci. 1999;4:D713–D730
   PubMedGoogle Scholar
• . Lippiello L. Collagen synthesis in tenocytes, ligament cells and chondrocytes exposed to a combination of glucosamine HCl and chondroitin sulfate. Evid Based Complement Alternat Med. 2007;4(2):219–224
   PubMed Web of Science ®Google Scholar
• . Chan PS, Caron JP, Rosa GJM, Orth MW. Glucosamine and chondroitin sulfate regulate gene expression and synthesis of nitric oxide and prostaglandin E2 in articular cartilage extracts. Osteoarthritis Cartilage. 2005;13:387–394
   PubMed Web of Science ®Google Scholar
• . Chan PS, Caron JP, Orth MW. Effects of glucosamine and chondroitin sulfate on bovine cartilage explants under long-term culture conditions. Am J Vet Res. 2007;68(7):709–715
   PubMed Web of Science ®Google Scholar
• . Clegg DO, Reda DJ, Harris CL, . Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N Engl J Med. 2006;354(8):795–808
   PubMed Web of Science ®Google Scholar
• . Das A Jr, Hammad TA. Efficacy of a combination of FCHG49 glucosamine hydrochloride, TRH122 low molecular weight sodium chondroitin sulfate and manganese ascorbate in the management of knee osteoarthritis. Osteoarthritis Cartilage. 2000;8(5):343–350
   PubMed Web of Science ®Google Scholar
• . Lipiello L, Nardo JV, Harlan R, Chiou T. Metabolic effects of avocado/soy unsaponifiables on articular chondrocytes. Evid Based Complement Alternat Med. 2008;5(2):191–197
   PubMed Web of Science ®Google Scholar
• . Bouic PJ. The role of phytosterols and phytosterolins in immune modulation: a review of the past 10 years. Curr Opin Clin Nutr Metab Care. 2001;4(6):471–475
   PubMed Web of Science ®Google Scholar
• . De Jong A, Plat J, Mensink RP. Metabolic effects of plant sterols and stanols (review). J Nutr Biochem. 2003;14(7):362–369
   PubMed Web of Science ®Google Scholar
• . Gupta MB, Nath R, Srivastava N, Shanker K, Kishor K, Bhargava KP. Anti-inflammatory and antipyretic activities of beta-sitosterol. Planta Med. 1980;39(2):157–163
   PubMed Web of Science ®Google Scholar
• . Au RY, Al-Talib TK, Au AY, Phan PV, Frondoza CG. Avocado soybean unsaponifiables (ASU) suppress TNF-alpha. IL-1 beta, COX-2, iNOS gene expression, and prostaglandin E2 and nitric oxide production in articular chondrocytes and monocyte/macrophages. Osteoarthritis Cartilage. 2007;15(11):1249–1255
   PubMed Web of Science ®Google Scholar
• . Al-Talib TK, Au RY, Phan PV, Au AY, Frondoza CG. Inhibition of pro-inflammatory cytokine and cox-2 expression in chondrocytes and monocytes by a avocado soybean unsaponifiables (ASU). Proceedings of the American College of Veterinary Internal Medicine (ACVIM) 2006. Abstract 160
   Google Scholar
• . Henroitin YE, Deberg MA, Crielaard JM, Piccardi N, Msika P, Sanchez C. Avocado/soybean unsaponifiables prevent the inhibitory effect of osteoarthritis subchondral osteoblasts on aggrecan and type II collagen synthesis by chondrocytes. J Rheumatol. 2006;33(8):1666–1678
   Web of Science ®Google Scholar
• . Blotman F, Maheu E, Wulwik A, Caspard H, Lopez A. Efficacy and safety of avocado/soybean unsaponifiables in the treatment of symptomatic osteoarthritis of the knee and hip. A prospective, multicenter, three-month, randomized, double-blind, placebo-controlled trial. Rev Rheum Engl Ed. 1997;64(12):825–834
   PubMedGoogle Scholar
• . Maheu E, Mazières B, Valat JP, . Symptomatic efficacy of avocado/soybean unsaponifiables in the treatment of osteoarthritis of the knee and hip: a prospective, randomized, double-blind, placebo-controlled, multicenter clinical trial with a six-month treatment period and a two-month followup demonstrating a persistent effect. Arthritis Rheum. 1998;41(1):81–91
   PubMed Web of Science ®Google Scholar
• . Appelboom T, Schuermans J, Verbruggen G, Henrotin Y, Reginster JY. Symptoms modifying effect of avocado/soybean unsaponifiables (ASU) in knee osteoarthritis. A double blind, prospective, placebo-controlled study. Scand J Rheumatol. 2001;30(4):242–247
   PubMed Web of Science ®Google Scholar
• . Lequesne M, Maheu E, Cadet C, Dreiser RL. Structural effect of avocado/soybean unsaponifiables on joint space loss in osteoarthritis of the hip. Arthritis Rheum. 2002;47(1):50–58
   PubMed Web of Science ®Google Scholar
• . Au RY, Au AY, Snow GE, . Cyclooxygenase-2 gene expression and prostaglandin-E2 production in activated equine osteoblasts are inhibited by avocado soybean unsaponifiables, glucosamine, and chondroitin sulfate. J Vet Intern Med. 2007;21(3):668
   Web of Science ®Google Scholar
• . Au AY, Au RY, Rshmir-Raven AM, Frondoza CG. Downregulation of cyclooxygenase-2 expression and prostaglandin-E2 production in equine chondrocytes and osteoblasts by avocado soybean unsaponifiables, glucosamine, and chondroitin sulfate. Proc Equine Sci Soc. 2007
   Google Scholar
• . Demko JL, Phan PV, Kramer EA, MCLaughlin R, Fronoza CG. Inhibition of prostaglandin E-2 production in chondrocyte microcarrier spinner cultures by the combination of avocado soy unsaponifiables, chondroitin sulfate, and glucosamine [abstract]. Proceedings of 34th Annual Conference of the Veterinary Orthopedic Society. Sun Valley, ID; March 3–10, 2007
   Google Scholar
• . Au RY, Au AY, Rashmir-Raven A, Frondoza CG. Inhibition of pro-inflammatory gene expression in chondrocytes, monocytes, and fibroblasts by the combination of avocado soybean unsaponifiables, glucosamine, and chondroitin sulfate. FASEB. 2007:21(6):702–707
   Web of Science ®Google Scholar
• . Au RY, Au AY, Rashmir-Raven AM, . Pro-inflammatory gene expression in chondrocytes and monocyte/macrophages is inhibited by the combination of avocado soybean unsaponifiables, glucosamine, and chondroitin sulfate. Proceedings of 34th Annual Conference of the Veterinary Orthopedic Society. Sun Valley, ID; March 3–10, 2007:57
   Google Scholar
• . Frondoza CG, Heinecke LF, Grzanna MW, Au AY, Rashmir-Raven AM. Modulation of metalloproteinase expression by the combination of avocado soy unsponifiables, glucosamine hydrochloride and chondrotin sulfate. Transactions of the 8th World Congress of the International Cartilage Repair Society; Miami, FL: May 23–26; 2009
   Google Scholar
• . Dougherty JJ, Heinecke LF, Grzanna MW, . Effect of phenylbutazone and the combination of avocado soybean unsaponifiables, glucosamine, and chondroitin sulfate on metalloproteinase activity in equine chondrocytes. Transactions of the American College of Veterinary Surgeons Symposium. The Surgical Summit. Washington DC: October 8–9, 2009
   Google Scholar
• . Grzanna MW, Ownby SL, Heinecke LF, Au AY, Fronoza CG. Inhibition of cytokine expression and prostaglandin E production in monocyte/macrophage-like cells by avocado/soybean unsaponifiables and chondroitin sulfate. J Compl Integrateive Med. 2010;7(1). http://www.bepress.com/jcim/vol7/iss1/10. Accessed June 1, 2010
   PubMedGoogle Scholar
• . Heinecke LF, Grzanna MW, Au AY, Mochal CA, Rashmir-Raven A, Frondoza CG. Inhibition of cyclooxygenase-2 expression and prostaglandin E2 production in chondrocytes by avocado soybean unsaponifiables and epigallocatechin gallate. Osteoarthritis Cartilage. 2010;18(2):220–227
   PubMed Web of Science ®Google Scholar
• . Singh R, Ahmed S, Islam N, Goldberg VM, Haqqi TM. Epigallocatechnin-3-gallate inhibits interleukin-1β-induced expression of nitric oxide synthase and production of nitric oxide in human chondrocytes. Arthritis Rheum. 2002;46(8):2079–2086
   PubMed Web of Science ®Google Scholar
• . Food and Drug Administration. Code of Federal Regulations. 21 CFR, Part 11; Part 111. Southampton, NJ: GMP Publications; 2009. Revised April 1, 2009
   Google Scholar
• . US Government Accountability Office. Testimony Before the Special Committee on Aging, US Senate; Herbal Dietary Supplements. Released May 26, 2010. GAO-10-662T
   Google Scholar
• . Russell AS, Aghazadeh-Habashi A, Jamali F. Active ingredient consistency of commercially available glucosamine sulfate products. J Rheumatol. 2002;29(11):2407–2409
   PubMed Web of Science ®Google Scholar
• . ConsumerLab. http://www.consumerlab.com. Accessed June 4, 2010
   Google Scholar
• . Oke SL, McIlwraith CW. Review of the Potential Indications and Contraindications for Equine Oral Joint Health Supplements. In: 54th Annual Convention of the American Association of Equine Practitioners – AAEP, 2008. San Diego, CA: American Association of Equine Practitioners; 2008
   Google Scholar
• . Oke SL. Indications and contraindications for the use of orally administered joint health products in dogs and cats. J Am Vet Med Assoc. 2009;234(11):1393–1397
   PubMed Web of Science ®Google Scholar
• . The Arthritis Foundation. http://www.arthritistoday.org/treatments/supplement-guide/supplement-buying-tips.php. Accessed June 1, 2010
   Google Scholar
• . US Department of Health and Human Services. Tips for the savvy supplement user: making informed decisions and evaluating information. http://www.fda.gov/Food/DietarySupplements/ConsumerInformation/ucm110567.htm. Accessed June 1, 2010
   Google Scholar
• . Zhang W, Nuki G, Moskowitz RW, . OARSI recommendations for the management of hip and knee osteoarthritis: part III: changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthritis Cartilage. 2010;18(4):476–499
   PubMed Web of Science ®Google Scholar
• . American Academy of Orthopaedic Surgeons (AAOS). Guideline on the Treatment of Osteoarthritis (OA) of the Knee. http://www.aaos.org/research/guidelines/guidelineoaknee.asp. Accessed March 30, 2010
   Google Scholar
• . Ronca F, Palmeiri L, Panicucci P, Ronca G. Anti-inflammatory activity of chondroitin sulfate. Osteoarthritis Cartilage. 1998;6( suppl A):14–21
   PubMed Web of Science ®Google Scholar
• . DiNubile NA. Glucosamine and chondroitin sulfate in the management of osteoarthritis. Postgrad Med. 2009:121(4);48–50
   PubMed Web of Science ®Google Scholar
• . Huskisson EC. Glucosamine and chondroitin for osteoarthritis. J Int Med Res. 2008;36(6):1161–1179
   PubMed Web of Science ®Google Scholar
• . Wright JG. A practical guide to assigning levels of evidence. J Bone Joint Surg Am. 2007;89(5):1128–1130
   PubMed Web of Science ®Google Scholar
• . GRADE Working Group. http://www.gradeworkinggroup.org. Accessed June 8, 2010
   Google Scholar